# Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT

> **NCT03530085** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- Conditioning
- Elderly

## Interventions

- **DRUG:** Decitabine
- **DRUG:** Busulfan (BU)
- **DRUG:** Fludarabine(Flu)

## Key facts

- **NCT ID:** NCT03530085
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-15
- **Primary completion:** 2021-04-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-12-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03530085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03530085, "Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03530085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*